Down-regulation of the organic cation transporter 1 of rat liver in obstructive cholestasis
- 1 May 2004
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Hepatology
- Vol. 39 (5), 1382-1389
- https://doi.org/10.1002/hep.20176
Abstract
The liver plays a major role in biotransformation and elimination of various therapeutic agents and xenobiotics, many of which are organic cations and substrates of the organic cation transporter 1 (Oct1, Slc22a1). Oct1 is expressed at the basolateral membranes of hepatocytes and proximal renal tubules. Although Oct1 is the major uptake mechanism in hepatocytes for many pharmaceutical compounds, little is known about the effects of liver injury on this process. Our aim was to investigate the effects of obstructive cholestasis on Oct1 expression and function in liver and kidney. The effects of bile duct ligation (BDL) on Oct1 protein, messenger RNA (mRNA) expression, and tissue localization were determined in rat liver and kidney with Western analysis, real‐time reverse transcriptase‐mediated polymerase chain reaction (RT‐PCR), and immunofluorescence. To assess Oct1 function, the model substrate tetraethylammonium ([14C]TEA) was administered intravenously to BDL and control rats and distribution of radioactivity was determined. Oct1 protein significantly decreased in cholestatic livers to 42.1 ± 17.7% (P < .001), 15.5 ± 4.7% (P < .05), and 8.6 ± 2.7% (P < .05) of controls after 3, 7, and 14 days, respectively, but not in kidneys. Hepatic Oct1 mRNA decreased to 77.2 ± 12.7%, 40.7 ± 8.1% (P < .05), and 50.3 ± 7.5% (P < .05) 3, 7, and 14 days after BDL, respectively. Tissue immunofluorescence corroborated these data. Hepatic accumulation of [14C]TEA in 14‐day BDL rats was reduced to 29.6 ± 10.9% of controls (P < .0005). In conclusion, obstructive cholestasis down‐regulates Oct1 and impairs Oct1‐mediated uptake in rat liver, suggesting that hepatic uptake of small cationic drugs may be impaired in cholestatic liver injury. (HEPATOLOGY 2004;39:1382–1389.)This publication has 32 references indexed in Scilit:
- Localization of organic cation transporters OCT1 and OCT2 in rat kidneyAmerican Journal of Physiology-Renal Physiology, 2000
- Role of organic cation transporters in the renal secretion of nucleosidesBiochemical Pharmacology, 2000
- ORGANIC CATION TRANSPORTERS IN INTESTINE, KIDNEY, LIVER, AND BRAINAnnual Review of Physiology, 1998
- Catecholamine transport by the organic cation transporter type 1 (OCT1)British Journal of Pharmacology, 1998
- Membrane Localization of the Electrogenic Cation Transporter rOCT1 in Rat LiverBiochemical and Biophysical Research Communications, 1998
- Cloning and Functional Expression of a Human Liver Organic Cation TransporterMolecular Pharmacology, 1997
- Electrogenic Properties and Substrate Specificity of the Polyspecific Rat Cation Transporter rOCT1Published by Elsevier BV ,1996
- Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1FEBS Letters, 1996
- Drug excretion mediated by a new prototype of polyspecific transporterNature, 1994
- A multispecific uptake system for taurocholate, cardiac glycosides and cationic drugs in the liverBiochemical Pharmacology, 1992